• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    新冠疫情視角下生物技術(shù)風(fēng)險化解與法律規(guī)制

    2021-08-17 16:22:50葛倩倩王金金
    科技與法律 2021年1期
    關(guān)鍵詞:生物技術(shù)新冠疫情法律規(guī)制

    葛倩倩 王金金

    Absract: Biotchnology risk response must be considered, before science and technology cautiously promotes the development and innovation of biotechnology for COVID-19 prevention and control, on the basis of risk prevention. The prevention and control of biosecurity threats should proceed within the law and properly handle the biotechnology risks in COVID-19 research under legal norms. The goal is to reshape the principles and attitudes for the development of biotechnology, to prevent and dissolve any ambiguity caused by the application of biotechnology, to create a suitable space for the growth of biotechnology under the rule of law, and to realize the harmonious development of biotechnology and human society under the regulation of law. The Biosecurity Law of the People's Republic of China was promulgated on October 17, 2020, improving the legal and normative system in the field of biotechnology and providing guidance for the healthy development of biotechnology. With the increasingly prominent position and the important role of biotechnology in national development systems, it is a critical legal proposition in the era of biotechnology to establish fair laws and regulations of biotechnology to achieve good governance in the field of life science, thereby establishing and protecting public welfare in the development process of biotechnology.

    Key words: biotechnology risks, risk mitigation, legal regulation, COVID-19 Pandemic

    CLC: D 912???????????????????? DC:A??????????????????????? Article ID:2096-9783(2021)01-0140-09

    1. Introduction

    The biosafety risks posed by biotechnology demonstrate the power of science and technology while showing that such technology involves huge hidden risks. The new round of the biotechnological revolution has penetrated all fields of human society and aroused the close attention of the international community. At a time when the global COVID-19 crisis requires urgent responses, the vast majority of countries and regions in the world have exposed weaknesses in their biosafety systems. In 2020, Liu Chong and Deng Wenjia point out that due to the global spread of COVID-19, the complex changes and wide application of emerging biotechnology have posed severe challenges to the system of balancing interests and risks established by traditional laws[1]. In 2019, Wang Xiaoli points out that the risk of biotechnology is the risk caused by the violation of the law of technology itself and the original intention of technology development in the process of human development and the utilization of biotechnology[2]. This risk is often characterized by great difficulty in prediction, strong economic and social relevance, and major threats to overall national security.

    Certain biomaterials, biotoxins in laboratories, potential pandemics, and introductions of invasive species into ecosystems have long been recognized as risk issues that affect public health and the environment. From bacteriology in the late 19th century, to aerobiology and virology in the mid-20th century, to biotechnology such as genetic engineering, gene editing and synthetic biology, hidden risks have always existed because of the "dual use" of technology. At the practical level, governments attach great importance to the risk of biotechnology. Countries such as America, Britain, and Australia have issued national strategies for biological safety to strengthen biological safety management at home and abroad. The overall goal is to build a comprehensive, international, biological defense system. The risk of biotechnology is also an important area of research for many institutions. The European Commission, the Royal Society, the German Research Foundation, and others have all carried out studies on biosafety, security risk assessment, and regulatory principles. In the academic world, Ghasemi and Karami (2019) point out that researchers have begun to pay attention to the ethical aspects of biotechnology issues, regarding morality and ethics as important factors affecting risk perception[3]. On the one hand, Van Wezel (2017) emphasizes the establishment of systematic risk prevention and control measures from the aspects of system, laws and regulations, ethics, and public opinion guidance[4]. On the other hand, in the era of globalization, Sandberg and Nelson (2020) point out that due to the differing regulatory approaches in different countries, most effectively managing the risks and benefits arising from the progress of gene technology requires a better understanding of the similarities and differences of the various national regulatory systems in[5]. There is a great need to strengthen global cooperation and establish multi-level prevention and protection actions. In general, in the process of studying the risks of biotechnology, scholars mainly focus on the frontier emerging fields of biotechnology and the forward-looking, pioneering, and exploratory major technologies in the field of biotechnology; they focus on the analysis of gene engineering and gene editing in the field of genetic engineering, as well as synthetic biology and other technical fields.

    Driven by the Third Technological Revolution, human society began to become what Ulrich Beck called a "risk society" in the 20th century. Technological risks represented by biological technologies such as gene editing, synthetic biology, and stem cell manipulation are rapidly rising to become the most important risks in a modern risk society. In 2006, WHO points out that lab biosafety and the narrow sense of technical biotechnology risk are two sides of the same coin, but the latter focuses on "the protection, control, and accountability of valuable biomaterials in the laboratory with the aim of preventing unauthorized access, loss, theft, abuse, transfer or intentional release"[6]. In the age of big data, Sture and Whitby (2013) point out that not only must biomaterials be well controlled, but "equal attention must be paid to information, knowledge, processes, practices, and equipment related to potentially or actually dangerous biomaterials"[7]. The major risk of biotechnology is that it is difficult to predict; has strong economic, social, and political relevance; and can greatly threaten overall national security. Problems exist: At the operational level, how do we define risks, who decides what those risks are, and how do we address them? Jasanoff and Sarewitz (2015) point out that the identification of technical risks is often made by the scientists themselves, rather than involving a broader group of stakeholders, which can lead to a rather narrow definition of the risks involved[8]. To this end, they suggest using a more inclusive and democratic approach to define and deal with risks.

    2 Risks in the Development of Biotechnology in the Context of COVID-19

    It is assumed that the COVID-19 outbreak started in Wuhan, China, in January 2020. By January 30, the number of confirmed COVID-19 cases had surpassed that of SARS in 2003. By August 27, China had reported 90,293 confirmed COVID-19 cases and 4,720 deaths. As of August 27, 2020, the disease had spread to 215 countries and regions, with more than 23 million cases and a confirmed death toll exceeding 810,000. Confirmed cases in the U.S. numbered above 5.85 million, and the U.S. cumulative death toll exceeded 1800001. Although COVID-19 is well under control in China, the force of COVID-19 is still strong in the international community. COVID-19 has brought pain to all humanity, and the epidemic is still spreading around the world, plunging the world economy into a severe recession. In the face of the COVID-19 pandemic, we need to recognize the inherent character of biotechnology, which, along with technological change and social interaction, benefits human society but also poses security threats and risks.

    2.1 Consideration of Ecosystem Security Risks

    Risk refers to the possibility or opportunity of suffering danger, loss, injury. From the perspective of safety science, risk is the possibility and consequence of a specific hazardous event. In this paper, risk refers to the harm that biotechnology may cause to human health or the ecological environment. Modern technologies, such as biotechnology, based on risk society theory, have brought human society into what Ulrich calls a "risk society", in which "productivity loses its innocence, wealth gains from technological progress and becomes increasingly the dark side of risk production." In this view, technology is not only a way to solve problems; it is also a troublemaker"[9]. The prosperity and development of biotechnology have gradually become an important force to promote the progress of human society and industrial innovation.

    Like other scientific and technological achievements, the development of biotechnology has a two-sided nature. On the one hand, it has solved many dilemmas such as food crises, environmental problems, human health issues, and energy problems for the development of humanity, and it has brought huge economic benefits. On the other hand, the development of biotechnology will inevitably produce internal and external negative effects. For example, this development can guarantee neither human health and safety nor ecological and environmental balance, as well as raising issues such as the right to know, privacy, and social ethics. In the face of the huge threat to human health brought by COVID-19, a series of diagnosis and treatment technologies and vaccine research and development have made outstanding contributions to the response to COVID-19 and the protection of human health. However, we cannot ignore the need to determine whether these diagnostic techniques and future vaccines will bring new unknown health risks.

    The most crucial goal of COVID-19 research is to prevent more people from getting the novel coronavirus, and to achieve this goal, the new vaccine research and development of China have been at the forefront of the world. The COVID-19 vaccine developed by Academician Chen Wei's team was the first, both domestically and internationally, to enter the phase I and phase II clinical trials, demonstrating the safety and immunogenicity of the vaccine. The vaccine's stage Ⅲ international clinical trial is proceeding. The vaccine uses technical intervention to form antibodies in the body that block the development of the virus and protect the body against its invasion. This process of human intervention, however, is actually the destruction of the original ecosystem; the essence of its operation is to create a new ecosystem, which can very easy to destroy the original ecosystem. Reactions, such as allergic and immunogenic reactions, can occur. Looking back at previous epidemics caused by coronaviruses, the virus mutates rapidly, and the antibodies produced by the vaccine protect against such epidemics for only three to six months. On the one hand, there is no data to support whether vaccination will bring adverse effects. On the other hand, it is not yet known whether the antibodies produced by the vaccine can resist the mutation of the virus. These risks are currently unknown.

    2.2 Consideration of Human Health Risks

    The development of biotechnology can meet the growing material and cultural needs of humankind, especially in food security, human health, energy security, and other aspects of outstanding value and significance. However, biotechnology is a double-edged sword, which needs to go through a long process to mature. Especially in the early stage of technology development, there are great safety risks in the process of the research, experimentation, and release of the results, and these risks are often uncontrollable and unknown. Many treatments have been used during the pandemic of COVID-19, and so far, the results have been good, but we do not know for sure that these treatments will not harm patients. In the fight against COVID-19, the joint research team from the Department of Life Science and Medicine and the First Affiliated Hospital of the University of Science and Technology of China (USTC) attracted much attention, and the team proposed the diagnosis and treatment plan of "Tozumab + routine treatment". The team found that interleukin-6 (IL-6) is an important pathway that induces inflammatory storms in patients with COVID-19[10]. This diagnosis and treatment scheme has been popularized in more than 20 countries worldwide and widely shared in international academic circles. However, abnormal liver function, skin damage, allergic reaction, gastrointestinal damage, infection, blood system damage, and other such adverse reactions may occur during the clinical use of Tozumab. Therefore, although Tozumab has achieved good results in the treatment of COVID-19, we should not ignore the risks that this drug brings.

    2.3 Consideration of Social Order and Ethical Risks

    The development of biotechnology will not only bring risks to ecological security, human health, resources, but also bring many ethical risks. "In the field of science and technology, which can bring great risks and disasters to mankind, the preconditions for free research have fundamentally changed dramatically" (Ulrich, 1986). Many biotechnologies set man against nature, and the course of life no longer follows the laws of nature but the will of man. The development of technology has changed the original ecological balance, which has led to many new problems. The origin of novel coronavirus has not yet been determined, but the over transformation of nature by humans must be responsible for it. Respect for social order and moral ethics is a necessary stipulation for the development of biotechnology. Otherwise, the balance between humanity and nature will be broken, and human beings will suffer bad consequences.

    3 Legal Provision of Biotechnology Safety Risks in China

    In the field of preventing the risk of infectious diseases outbreak, China's legal basis mainly includes the Emergency Response Law, the Law on the Prevention and Treatment of Infectious Diseases, the Frontier Health and Quarantine Law, and the Regulations for Emergency Response to Public Health Emergencies, which constitute the basic legal framework of China's response to public health emergencies. However, under the challenge of the epidemic, many shortcomings in the provisions of the law have been exposed. In 2020, the new Biosecurity Law included infectious diseases in the category of biosafety, which was elevated to the height of national security and provided precise legal positioning for infectious diseases. However, the authorization of local governments for emergency treatment measures still needs to be further enriched and improved. Taking the epidemic as an example, there are no clear provisions detailing the isolation of high-risk groups and whether cities can be "closed down".

    In the field of preventing the misuse and abuse of biotechnology, China issued the Regulations on the Export Control of Dual-use Biological Agents and Related Equipment and Technologies in 2002, the Measures for the Ethical Review of Biomedical Research Involving Human Beings in 2016, and the Measures for the Safety Management of Biotechnology Research and Development in 2017. These specifications aim to regulate biological technology research and development, promoting and safeguarding the healthy development of biotechnology. Biosafety risks and responsibilities are stipulated in the research and development and commercial application of biotechnology. The newly promulgated Biosecurity Law has many principle provisions on the research and development and application of biotechnology, but there should still be supplementary legislation to ensure the law's implementation. Relevant legislative guidance is an important guarantee for dealing with a major epidemic. In the early stage of the COVID-19 outbreak, due to the lack of supporting legislative guidance, researchers were not qualified to provide guidance and support on the scene of such sudden outbreak of biosafety incidents, so they could only quickly set up emergency response teams. The USTC team is one of them, and it succeeded in quickly identifying the virus and putting forward a treatment plan. With appropriate legislative guidance, such teams could have stepped in with legal guidance at the beginning of an outbreak, but the current legislation in this area is lacking.

    In the field of preventing biotechnological ecological security risks, China's legislation needs strengthening. Biotechnology ecological security risk prevention is a complex systematic project which needs a scientific, reasonable, coordinated, and powerful operation system to ensure the efficient and orderly development of ecological security management[11]. The Measures for The Safety Management of Genetic Engineering issued by the former State Science and Technology Commission (now the Ministry of Science and Technology) in 1993 was China's first legal norm in the field of biotechnology safety; it regulates all the behaviors related to gene research in China. In 2001, in accordance with the relevant provisions of the Cartagena Protocol on Biosafety, the Chinese State Council promulgated the Regulations on the Safety management of Agricultural GMOs, which is the first administrative regulation regulating the safety of biotechnology in China. In China, ecological security risk prevention norms of biotechnology mainly focus on the field of gene technology. In addition, no other normative documents regulate ecological security risks in China[12]. At present, China lacks a complete legislation system for the prevention of biotechnological ecological security risks, especially for such biosafety incidents as COVID-19; such legislation is urgently needed.

    4 Experiences of the Major Countries in the Legal Regulation of Biotechnology Risks

    With the increasing technological risks in major biosecurity fields, such as the study of epidemics, technological optimism has been questioned. Interested parties wonder whether the law should unconditionally protect the freedom of scientific research; the question of whether the country should not put any scientific issues off-limits has become a new issue that needs to be urgently addressed. The freedom of scientific research is not absolute; it should be constrained by both nature and ethics, so it is necessary to use the legal system to set restricted areas for scientific issues[13]. The typical biosafety legislation of various countries is of great significance, especially considering the experience of big countries in the legal regulation of biosafety, R&D, and application of biotechnology.

    4.1 The United States: Adopting the Principle of Substantive Equivalence to Encourage the Development of Technology

    In the field of biosafety management, the United States advocates the principle of substantive equivalence. This principle refers to the identification of a traditional transaction without the possibility of determining whether there is a risk for it. The United States advocates the freedom of scientific research. When the safety risks of biotechnology have not been confirmed by science, the United States government will not impose very strict management and restrictions on scientific research of biotechnology.

    In the field of biotechnology safety regulation, the United States has established a series of technical evaluation standards for the safety, R&D, application, and other facets of biotechnology, mainly through relevant experience in the history of technology development. For the development of cutting-edge technologies, including biotechnology, a relatively relaxed and encouraging policy has been adopted. The green light has been given to many biotechnology projects, including synthetic biotechnology, on the premise that the source of risk can be controlled, so there is no resistance to their development.

    In 1976, the National Institutes of Health (NIH) of the United States formulated the Recombinant Gene Molecular Research Guidelines, which stipulated the safety management of transgenic technology and the responsibility of the experimenter, also setting a precedent for the legal protection of biotechnology safety. In 1986, the United States government authorized the Department of Agriculture, Environmental Protection Agency, Food and Drug Administration, Occupational Safety and Health Administration, and National Institutes of Health to coordinate the management of safe progress in biotechnology. With the Recombinant Gene Molecular Research Guidelines as the main framework, the United States has successively issued the Manual for Biological Safety in Microbiology and Biomedical Laboratories; the Preservation, Use and Transfer of Selective Agents and Toxins; the Development Policy Guidelines and Suggestions on the Management and Supervision and Review Mechanism of Potential Pandemic Pathogens; the Standard Operating Procedures for Biological Safety in Laboratories of the United States, and the Training Guidelines for Standard Operating Procedures for Microbiology Laboratories Personnel; these documents all regulate biological operations. Along with the Concern on Biosafety and Biotech Dual-use Research, the US Government's Regulatory Policy on Biosafety and Biotechnology Dual-use Research, these norms constitute the legal and normative system in the field of biotechnology in the United States[14]. The National Biodefense Strategy, released in 2018 included the intentional misuse of biotechnology in the list of national biosecurity threats for the United States and tested the implementation of the national biosecurity strategy. The National Health Security Strategy Implementation Plan 2019-2022, released in the same year, emphasized the need to strengthen the management of microbiological agents and actively respond to biosecurity threats. It has to be said that the United States has made a series of explorations in biotechnology risk prevention and control.

    4.2 Europe: Adopt the Precautionary Principle to Treat Technical Risks Prudently

    Compared to the U.S., which has encouraged the development of biotechnology, the Europeans are more conservative. Europe has adopted the precautionary principle in the field of biotechnology; that is, measures to prevent the occurrence of hazards are not be taken on the grounds of the uncertainty of biotechnology. According to the principle of risk prevention, biotechnology involves great uncertainty, and once the risk occurs, its damage consequences are often incalculable. Therefore, even if the current scientific evidence proves that the damage might not happen, certain preventive measures should be taken. Most European countries insist that biotechnology research that poses safety risks is monitored with caution.

    The regulation of biotechnology is stricter in European countries than in the U.S., especially for biotechnology and the products derived from it, which are often regulated by stringent legislation. The EU has formulated ten regulations, six directives, and six resolutions in the field of biotechnology, such as gene technology[15]. All the regulations have legal effect in each Member State, and each Member State needs to improve its national legislation within the specified time under the directive's requirements.

    To facilitate the management of gene-editing technology, Germany has successively issued the Recombination Gene Molecular Experiment Criteria, Gene Technology Law, Gene Technology Safety Regulations, and Embryo Protection Law. Germany's Biotechnology Law came into effect formally in 1990. The law controls the development and application of biotechnology, delineates the regulatory authority for biotechnology, and stipulates the liability for compensation for damage caused by biotechnology and products. The law was designed to prevent the risks that may be brought by biotechnology and products. In the past two years, Britain issued a series of strategies related to the field of biotechnology, including the National Industrial Biotechnology Strategy 2030, 2030 National Biological Economic Strategy, and Solve the Antimicrobial Drug Resistance in 2019-2024: The British National Action Plan for 5 Years. Britain proposed to make full use of biological technology to improve the structure of its national economy but specified that attention should be paid to limiting biological technology that may bring huge risks.

    4.3 China: Managing the Balance Between Risk Prevention and Prudent Development of Biotechnology

    Article 2 of China's Biosecurity Law mandates adherence to the principles of people-orientation, risk prevention, classified management, and coordination. While encouraging the innovation and development of biotechnology, the paper proposes to follow the principles of risk prevention and cautious development. Biotechnology is often closely related to the development of human society. Once risks are translated into reality, the consequences are often very serious and irreversible. Therefore, it is necessary to establish the principle of risk prevention. The principle of prudent development seeks a balance between the security of biotechnology and the development of biotechnology; this principle provides theoretical guidance for the construction of a legal system to ensure the security of biotechnology, and thus lays a foundation for the realization of justice and order. Adhering to the principles of risk prevention and prudent development is a path that must be followed by the rule of law to ensure the healthy development of biotechnology in China[16].

    At present, the legislation on biotechnology safety in China is composed of more than 90 laws, regulations, rules, and normative documents, dominated by the Biosecurity Law. The Biosecurity Law is a fundamental and comprehensive law in the field of biotechnology. Most of the regulations in the field of biotechnology other than biosecurity Law are administrative regulations formulated by the competent authorities of the industry. Although these other protocols provide a way to promote biotechnology safety in specific fields, some of them are old and cannot meet the needs of the current development of biotechnology. So far, China's current regulations and norms in the field of biotechnology have played a certain role in protecting the development of biotechnology[17]. However, to ensure the sustainable and healthy development of biotechnology, there is still a long way to go for the rule of law based on risk prevention and prudent development.

    5 Improvement of Legal Regulations on Major Risks of Biotechnology

    Apart from the Biosecurity Law, the current legislation in the field of biotechnology enforced at a low level of government and was promulgated too long ago to meet the challenges brought by the rapid development of biotechnology. After the outbreak of COVID-19, attention was once again attached to the topic of biosafety, and since biosafety is related to national security, the national Biosecurity Law came into being, which is bound to play a major guiding role in the development of biotechnology. We believe that under the legal norm system in the field of biotechnology dominated by the Biosecurity Law, the legal regulation of biotechnology can be improved in the following aspects.

    5.1 Formulation of Laws Supporting the Biosecurity Law

    From the perspective of legislative orientation, the Biosecurity Law is more like the basic law with broad regulatory scope and strong principles. From the perspective of content, the Biosecurity Law mainly provides the general provisions for biosafety. The promulgation of the Biosecurity Law has provided guidance for the healthy development of biotechnology, but biotechnology is complex and needs to be regulated by complete and detailed legal provisions. It is very important to formulate special laws to assist the better implementation of the Biosecurity Law. Taking the safety of human genetic resources and biological resources as an example, the Biosecurity Law stipulates that the collection, preservation, utilization, and provision of human genetic resources in China shall protect human health and safeguard national security and social and public interests[18]. The Biosecurity Law considers exact definition: the interpretation of human genetic resources is narrowed to human genetic resources with or without modification, which covers modified genetic resources such as those produced by transgenic technology, gene editing techniques, and synthetic biology technology.

    5.2 Legislation on the Public Compensation Mechanism

    At present, China has no relevant provisions on public compensation in any biotechnology-related legal norm, but the public compensation system is an important link in dealing with public safety accidents, so inevitably, the government must formalize and enact a comprehensive public system. Take this epidemic as an example, COVID-19 has not only harmed people's health but also caused serious economic losses and even economic stagnation. Biotechnology safety accidents typically cause economic losses within a certain range. Some of the damage is caused by the government's administrative action, and this loss cannot be compensated through the tort liability system. The biotechnology legislation on the public compensation system should be clear about dealing with such economic loss if it is caused by biotechnology safety accidents. As for public compensation funds, they may be incorporated into the government fiscal budget, or special security funds may be set up by governments at all levels as a source of compensation. As for the standard of compensation, we can refer to the local price level and the actual loss to give careful consideration. In addition, enterprises can be given preferential tax policies, and citizens can be given preferential policies.

    5.3 Legislation on the Professional Ethics of Scientific Researchers

    Many risks induced in the development and application of biotechnology are both ethical and legal. The inclusiveness between ethics and law provides feasibility for establishing a legal framework for the professional ethics of scientific researchers. There are few related laws at present regulating researchers in China, China lacks science and technology progress law, administrative rules, and other regulatory documents for most kinds of scientific research personnel; systematic, consistent rules for the scope of their duties are needed to coordinate such research efforts[19]. In addition, China's relevant laws and regulations on scientific researchers are dominated by the idea of encouraging the development of science and technology. Although there are provisions relating to legal responsibility, there is a lack of content specifically addressing legal responsibility, making the legal norms lack operability.

    5.4 Strengthening of the Legal Principle of Extensive International Cooperation

    Biotechnology risks are global in character. Guided by the vision of building an international community with a shared future for humanity, countries around the world are working to develop and improve the global rules of co-governance of biotechnology risks. China's newly promulgated Biosecurity Law incorporates into its legal principles the concept of a community with a shared future for humankind, plans extensive international cooperation on biotechnology security using this concept, and seeks to build a strategic consensus for the development of emerging biotechnology in the international community. In the global fight against the COVID-19 pandemic, China should actively advocate a global biotech safety net, form a truly feasible international agreement, and try hard to put it into practice. China should actively participate in formulating or amending international biotechnology rules and standards among the surrounding countries, regions, and regional organizations. Efforts should be made to popularize advanced ideas and to express the interests of all parties.

    6 Conclusion

    Both the significant innovation progress and the emerging risk threat of biotechnology will become hot spots of academic exploration and focuses of public opinion. Law is the prerequisite and the foundation to ensure that biotechnology development advances on the track of promoting scientific and technological innovation and maintaining social welfare. Chinese current legislation on biotechnology are few and dated and need to be improved. The establishment of a scientific management system adapted to the actual needs of biotechnology and the effective connection with the existing legislation will provide a more solid legal basis for strengthening the legal system construction of biotechnology safety and safeguarding national security.

    It can be seen from the above discussion that attention should be paid to the risks of biotechnology in order to improve the legislation in the field of biotechnology in China and guarantee the development of technology on the basis of current laws and by referring to advanced foreign legislation.

    References:

    [1] Liu Chong, Deng Menja. The Impact of Emerging Biotechnology Development on Great Power Competition and Global Governance[J]. Modern International Relations, 2020(6): 1-10.

    [2] Wang Xiaoli. Biosafety Era: New Biosafety Transformation and National Security Governance[J]. International Security Studies, 2020, 38(4): 109-135.

    [3] Ghasemi, S., Ahmadvand, M., Karami, E. et al. Social Risk Perceptions of Genetically Modified Foods of Engineers in Training: Application of a Comprehensive Risk Model[J]. Science and Engineering Ethics, 2019: 25.

    [4] Van Wezel A P, Van Lente H, Van d S J M, et al. Risk analysis and Technology Assessment in Support of Technology Development: Putting Responsible Innovation in Practice in a Case Study for Nanotechnology[J]. Integrated Environmental Assessment and Management, 2017: 9-16.

    [5] Sandberg Anders,Nelson Cassidy. Who Should We Fear More: Biohackers, Disgruntled Postdocs, or Bad Governments? A Simple Risk Chain Model of Biorisk.[J]. Health Security, 2020, 18(3): 9.

    [6] Health Organization (WHO). (2006). Biorisk Management: Laboratory Biosecurity Guidance. Retrieved from http://www.who.int/ihr/publications/WHO_CDS_EPR_2006_6.

    [7] Sture, J., Whitby, S., & Perkins, D. Biosafety, Biosecurity and Internationally Mandated Regulatory Regimes: Compliance Mechanisms for Education and Global Health Security[J]. Medicine, Conflict and Survival, 2013, 29(4), 289-321.

    [8] Jasanoff, S., Hurlbut, J. B., & Saha, K. CRISPR Democracy: Gene Editing and the Need for Inclusive Deliberation. Issues in Science and Technology.? 2015,32.

    [9] Zhang Zhiyu, Liu Xiaobing. On the Legal Prevention of Ecological Security Risks of Biotechnology[J]. China's Environmental Rule of Law, 2014(2): 1-24.

    [10] Wang Tao. Analysis of the Mechanism of Action and Safety Risk of COVID-19 Immunotherapy Drug Tozumab[J]. Pharmacovigilance in China, 2020, 17(5): 257-260.

    [11] Zhang Hui. Legislation Appeal of Biosafety[J]. Modern Law, 2008(6): 147-156.

    [12] Wang Kang. Legislation Orientation of Biosecurity Law and Risk Control of Gene Technology[J]. Journal of Beijing University of Aeronautics and Astronautics (Social Science Edition), 2019, 32(5): 27-29.

    [13] Ding Guomin, Guo Shijie. The Value Conflict and Solution of Biosafety Legislation[J]. Journal of Shanxi University (Philosophy and Social Sciences Edition), 2020, 43(4): 89-95.

    [14] Du Lu. Brief Discussion on Foreign Biosafety Legislation[J]. Legal System and Economy (Late Edition), 2014(5): 4-5.

    [15] Xue Yang, Yu Hanzhi. Security Threats of the Development of Frontier Biotechnology: Countermeasures and Prospects[J]. International Security Studies,2020,38(4): 136-156.

    [16] Yu Wenxuan. Rule of Law Principle and Realization Path of Biosafety Guarantee[J]. Exploration and Controversy, 2020(4): 160-166.

    [17] Liu Xuxia. Biosafety Law Should Highlight The Safety Prevention of Biotechnology[J]. Journal of Beijing University of Aeronautics and Astronautics (Social Science Edition), 2019, 32: 25-26.

    [18] Yang J W. Construction of Collaborative Management Mode of Gene Risk under the Background of National Biosafety Risk Prevention and Control System[J]. Journal of China University of Political Science and Law, 2020(3): 149-159.

    [19] Fu Qian. Research on the Legalization of Professional Ethics of Contemporary Chinese Researchers[D]. Northeastern University, 2014: 11-13.

    新冠疫情視角下生物技術(shù)風(fēng)險化解與法律規(guī)制

    葛倩倩,王金金*

    (中國科學(xué)技術(shù)大學(xué)? 公共事務(wù)學(xué)院,合肥 230026)

    摘??? 要:生物技術(shù)風(fēng)險應(yīng)對必須走到科技的前面去,在風(fēng)險預(yù)防的基礎(chǔ)上審慎推動新冠疫情防治生物技術(shù)的發(fā)展創(chuàng)新;對生物安全威脅的防控更應(yīng)走到法律的內(nèi)部去,在法律規(guī)范下妥善處置新冠疫情中的生物技術(shù)風(fēng)險。重塑發(fā)展生物技術(shù)的原則和態(tài)度,防范和化解生物技術(shù)應(yīng)用產(chǎn)生的陰霾,創(chuàng)設(shè)適宜的生物技術(shù)生長的法治空間,實現(xiàn)在法律規(guī)制下的生物技術(shù)與人類社會的協(xié)調(diào)向善發(fā)展。2020年10月17日《中華人民共和國生物安全法》頒布,完善了生物技術(shù)領(lǐng)域法律規(guī)范體系,為生物技術(shù)健康發(fā)展提供導(dǎo)向。隨著生物技術(shù)在國家發(fā)展體系中的地位日益突出、作用日益重要,探索規(guī)范生物技術(shù)之良法以求生命科學(xué)領(lǐng)域之善治,以求在生物技術(shù)發(fā)展進程中確立和保障社會公益,是生物科技時代的重大法治命題。

    關(guān)鍵詞:生物技術(shù);風(fēng)險化解;新冠疫情;法律規(guī)制

    猜你喜歡
    生物技術(shù)新冠疫情法律規(guī)制
    新冠疫情視閾下感悟“四個自信”國家共識
    “心理成長任務(wù)包”助力學(xué)生安度疫情
    關(guān)于疫情對地區(qū)經(jīng)濟金融影響情況的調(diào)研
    新冠疫情對縣域脫貧產(chǎn)業(yè)發(fā)展的影響及地方金融支持的建議
    生物技術(shù)在環(huán)保工程中的應(yīng)用
    淺析生物技術(shù)在水污染治理中的應(yīng)用
    高職院校生物技術(shù)專業(yè)《生物化學(xué)》教學(xué)現(xiàn)狀與對策
    科技視界(2016年26期)2016-12-17 20:36:02
    淺析林業(yè)育種和生物技術(shù)的應(yīng)用
    商業(yè)預(yù)付卡經(jīng)營行為的法律規(guī)制
    我國網(wǎng)絡(luò)經(jīng)濟中不正當競爭行為的法律規(guī)制
    404 Not Found

    404 Not Found


    nginx
    日韩三级伦理在线观看| 亚洲精品456在线播放app| 午夜精品一区二区三区免费看| 欧美不卡视频在线免费观看| 亚洲成人精品中文字幕电影| 国产一区二区亚洲精品在线观看| 国产片特级美女逼逼视频| 亚洲av电影不卡..在线观看| 欧美+日韩+精品| 一区二区三区高清视频在线| 777米奇影视久久| 69av精品久久久久久| 99热6这里只有精品| 国产色爽女视频免费观看| 国产一区二区三区综合在线观看 | 亚洲天堂国产精品一区在线| 国产白丝娇喘喷水9色精品| 亚洲av国产av综合av卡| 精品久久国产蜜桃| 国产精品一区www在线观看| 国产 一区 欧美 日韩| 十八禁网站网址无遮挡 | 久热久热在线精品观看| 天天一区二区日本电影三级| 亚洲成人中文字幕在线播放| 日日干狠狠操夜夜爽| 成年免费大片在线观看| 中文资源天堂在线| av在线观看视频网站免费| 男女边吃奶边做爰视频| 男人和女人高潮做爰伦理| 狠狠精品人妻久久久久久综合| 在线播放无遮挡| av网站免费在线观看视频 | 亚洲av电影不卡..在线观看| 久久久久久久久久久免费av| 九九久久精品国产亚洲av麻豆| 青青草视频在线视频观看| 国产片特级美女逼逼视频| 国产色婷婷99| 91久久精品电影网| 久久精品综合一区二区三区| 亚洲人与动物交配视频| 免费av观看视频| 永久免费av网站大全| 亚洲av.av天堂| 91久久精品国产一区二区成人| 色视频www国产| 少妇的逼水好多| 纵有疾风起免费观看全集完整版 | 狠狠精品人妻久久久久久综合| 搞女人的毛片| 国产一区二区在线观看日韩| 丰满少妇做爰视频| 久久精品国产亚洲av天美| www.av在线官网国产| 在线观看av片永久免费下载| 成人毛片a级毛片在线播放| 插逼视频在线观看| 日本一二三区视频观看| 一区二区三区免费毛片| 亚洲av免费高清在线观看| av黄色大香蕉| 国产精品久久久久久久电影| 日本wwww免费看| 亚洲aⅴ乱码一区二区在线播放| 最近2019中文字幕mv第一页| 一区二区三区乱码不卡18| 日韩av在线免费看完整版不卡| 人人妻人人澡人人爽人人夜夜 | 久久精品人妻少妇| 亚洲精品成人久久久久久| 亚洲av.av天堂| 午夜亚洲福利在线播放| 亚洲精品亚洲一区二区| 亚洲国产高清在线一区二区三| 三级男女做爰猛烈吃奶摸视频| 精品不卡国产一区二区三区| 你懂的网址亚洲精品在线观看| 国产熟女欧美一区二区| 好男人在线观看高清免费视频| 亚洲精品国产av成人精品| 亚洲国产色片| 成人鲁丝片一二三区免费| 成年免费大片在线观看| 熟妇人妻不卡中文字幕| 色尼玛亚洲综合影院| 老女人水多毛片| 亚洲三级黄色毛片| 看黄色毛片网站| 日韩成人伦理影院| 成人亚洲欧美一区二区av| 国产女主播在线喷水免费视频网站 | 日韩人妻高清精品专区| 天堂√8在线中文| 男插女下体视频免费在线播放| 亚洲天堂国产精品一区在线| 人妻夜夜爽99麻豆av| 精品久久国产蜜桃| 干丝袜人妻中文字幕| 亚洲在久久综合| 亚洲精品日韩av片在线观看| 在线观看免费高清a一片| 99热这里只有精品一区| 欧美不卡视频在线免费观看| 国产一区亚洲一区在线观看| 最后的刺客免费高清国语| 精品人妻一区二区三区麻豆| 三级男女做爰猛烈吃奶摸视频| 高清日韩中文字幕在线| 亚洲四区av| 国产淫语在线视频| 亚洲精品日韩在线中文字幕| 丝袜美腿在线中文| 丝袜喷水一区| 精品熟女少妇av免费看| a级毛片免费高清观看在线播放| 免费黄色在线免费观看| 国内精品一区二区在线观看| 又粗又硬又长又爽又黄的视频| 国产老妇伦熟女老妇高清| 成人欧美大片| 黄片无遮挡物在线观看| 精品久久久精品久久久| 天堂av国产一区二区熟女人妻| 日韩精品青青久久久久久| 中国国产av一级| 国产一级毛片在线| 夫妻性生交免费视频一级片| 国产成人福利小说| 免费在线观看成人毛片| 99久久九九国产精品国产免费| 色综合亚洲欧美另类图片| 插阴视频在线观看视频| 欧美变态另类bdsm刘玥| 亚洲精品日韩在线中文字幕| 国模一区二区三区四区视频| 久久这里有精品视频免费| 日韩人妻高清精品专区| 18禁在线无遮挡免费观看视频| 国产在线一区二区三区精| 国产精品1区2区在线观看.| 又大又黄又爽视频免费| 久久久久网色| 久久久久久久久中文| 日韩精品青青久久久久久| 久久综合国产亚洲精品| 熟妇人妻不卡中文字幕| 国产女主播在线喷水免费视频网站 | 精品久久久久久成人av| av在线蜜桃| 一级a做视频免费观看| 人妻系列 视频| 精品少妇黑人巨大在线播放| 亚洲精品色激情综合| 亚洲综合精品二区| 小蜜桃在线观看免费完整版高清| 午夜福利在线在线| 一区二区三区乱码不卡18| 欧美一级a爱片免费观看看| 午夜日本视频在线| 性插视频无遮挡在线免费观看| 日本一本二区三区精品| 久久99蜜桃精品久久| 久久6这里有精品| 真实男女啪啪啪动态图| 国产午夜精品久久久久久一区二区三区| 一二三四中文在线观看免费高清| 青春草视频在线免费观看| 亚洲精品乱码久久久久久按摩| 美女xxoo啪啪120秒动态图| 极品教师在线视频| 亚洲av日韩在线播放| 激情五月婷婷亚洲| 亚洲av不卡在线观看| 国产有黄有色有爽视频| 一级二级三级毛片免费看| 午夜精品国产一区二区电影 | 国产老妇女一区| 午夜福利在线在线| 亚洲久久久久久中文字幕| 亚洲av在线观看美女高潮| 人人妻人人看人人澡| 国产真实伦视频高清在线观看| 久久午夜福利片| 国产色爽女视频免费观看| 亚洲精品亚洲一区二区| 美女内射精品一级片tv| 日韩一区二区视频免费看| 亚洲欧美精品专区久久| 久久久久九九精品影院| 欧美日本视频| 爱豆传媒免费全集在线观看| 国产精品久久久久久久久免| 亚洲精品aⅴ在线观看| av在线播放精品| 极品少妇高潮喷水抽搐| 街头女战士在线观看网站| 国产精品久久视频播放| 国产伦理片在线播放av一区| 最近最新中文字幕免费大全7| 亚洲成人久久爱视频| 亚洲,欧美,日韩| 搡女人真爽免费视频火全软件| 久久久久网色| 免费av不卡在线播放| 色哟哟·www| 欧美日韩亚洲高清精品| 国产一级毛片七仙女欲春2| 欧美性猛交╳xxx乱大交人| 国产久久久一区二区三区| 国产精品一区二区性色av| 欧美日韩视频高清一区二区三区二| 尤物成人国产欧美一区二区三区| 亚洲乱码一区二区免费版| 日韩欧美精品免费久久| 成人毛片a级毛片在线播放| 在线观看美女被高潮喷水网站| 日日啪夜夜爽| 少妇人妻一区二区三区视频| 简卡轻食公司| .国产精品久久| 九色成人免费人妻av| 成人二区视频| 日韩av不卡免费在线播放| 日日摸夜夜添夜夜爱| a级一级毛片免费在线观看| 日韩av在线免费看完整版不卡| 久久久久久久久大av| 国产精品一区二区三区四区免费观看| 欧美xxⅹ黑人| 精品一区二区免费观看| 婷婷色综合www| 99久久精品一区二区三区| 22中文网久久字幕| 在线免费观看的www视频| 女人十人毛片免费观看3o分钟| 人妻少妇偷人精品九色| 国产 一区 欧美 日韩| 天天一区二区日本电影三级| 精品不卡国产一区二区三区| 菩萨蛮人人尽说江南好唐韦庄| 一级毛片电影观看| 久久韩国三级中文字幕| 一本久久精品| 成年av动漫网址| 伊人久久精品亚洲午夜| 人人妻人人澡欧美一区二区| 欧美另类一区| 在现免费观看毛片| 亚洲人成网站高清观看| 国产不卡一卡二| 在线 av 中文字幕| 久久久久久久久久久免费av| 久久99热这里只频精品6学生| 久久精品熟女亚洲av麻豆精品 | 激情 狠狠 欧美| 精品人妻熟女av久视频| 一个人看的www免费观看视频| 九九久久精品国产亚洲av麻豆| 好男人视频免费观看在线| 欧美日本视频| 亚洲欧洲日产国产| 老女人水多毛片| 精品久久久久久久久亚洲| 午夜爱爱视频在线播放| 寂寞人妻少妇视频99o| 一区二区三区四区激情视频| 尾随美女入室| 一级a做视频免费观看| 亚洲久久久久久中文字幕| 久久99精品国语久久久| 在线免费十八禁| 久久久久久久久久久免费av| 国精品久久久久久国模美| 国产欧美日韩精品一区二区| 最近最新中文字幕免费大全7| 国产一级毛片在线| av在线观看视频网站免费| 日本欧美国产在线视频| 波野结衣二区三区在线| 国产黄片视频在线免费观看| kizo精华| 久久久久久久午夜电影| 精品久久久噜噜| 看非洲黑人一级黄片| 青春草国产在线视频| 国产成人精品久久久久久| 色播亚洲综合网| 亚洲性久久影院| 国产成人福利小说| 午夜久久久久精精品| 街头女战士在线观看网站| 精品一区二区三区视频在线| 国内精品美女久久久久久| 91精品伊人久久大香线蕉| 国产伦在线观看视频一区| 久久精品综合一区二区三区| 国产激情偷乱视频一区二区| 又粗又硬又长又爽又黄的视频| 又爽又黄a免费视频| 国产精品福利在线免费观看| 六月丁香七月| av线在线观看网站| 国产精品一区www在线观看| 伊人久久国产一区二区| 最近中文字幕2019免费版| 国产成人免费观看mmmm| 亚洲av免费高清在线观看| 国产成人午夜福利电影在线观看| 国产女主播在线喷水免费视频网站 | 久久久久久国产a免费观看| 18禁裸乳无遮挡免费网站照片| 国产精品伦人一区二区| 中文资源天堂在线| 免费看a级黄色片| av一本久久久久| 直男gayav资源| 你懂的网址亚洲精品在线观看| 久久久国产一区二区| 国产中年淑女户外野战色| 日日摸夜夜添夜夜添av毛片| 亚洲成人精品中文字幕电影| 搡老妇女老女人老熟妇| 99热6这里只有精品| 亚洲无线观看免费| 日韩一本色道免费dvd| 我要看日韩黄色一级片| 女人被狂操c到高潮| 国产伦一二天堂av在线观看| 亚洲av国产av综合av卡| 69人妻影院| 精品99又大又爽又粗少妇毛片| 免费无遮挡裸体视频| 97超视频在线观看视频| 一本一本综合久久| 免费人成在线观看视频色| 搞女人的毛片| 久久精品熟女亚洲av麻豆精品 | av国产免费在线观看| 国产成人aa在线观看| 两个人的视频大全免费| 国内精品宾馆在线| 日本黄大片高清| 久久午夜福利片| 免费大片黄手机在线观看| 美女xxoo啪啪120秒动态图| 赤兔流量卡办理| 国产一区二区亚洲精品在线观看| 80岁老熟妇乱子伦牲交| 色哟哟·www| 国产成人精品一,二区| 久久99热这里只有精品18| 午夜精品国产一区二区电影 | 免费电影在线观看免费观看| 国产乱人偷精品视频| 3wmmmm亚洲av在线观看| 成人鲁丝片一二三区免费| 国产精品国产三级专区第一集| 午夜激情福利司机影院| 亚洲av中文av极速乱| 精品人妻熟女av久视频| 日韩av在线免费看完整版不卡| 六月丁香七月| 成人亚洲精品一区在线观看 | 街头女战士在线观看网站| 国产中年淑女户外野战色| 日韩人妻高清精品专区| 非洲黑人性xxxx精品又粗又长| 男的添女的下面高潮视频| 五月天丁香电影| 全区人妻精品视频| 国产片特级美女逼逼视频| 两个人的视频大全免费| 亚洲成人久久爱视频| 久久久亚洲精品成人影院| 亚洲人与动物交配视频| 只有这里有精品99| 亚洲精品中文字幕在线视频 | 成人av在线播放网站| 欧美日韩一区二区视频在线观看视频在线 | 一级a做视频免费观看| 青春草视频在线免费观看| 777米奇影视久久| 大又大粗又爽又黄少妇毛片口| 亚洲自偷自拍三级| 成人一区二区视频在线观看| 日本猛色少妇xxxxx猛交久久| 大又大粗又爽又黄少妇毛片口| 亚洲熟妇中文字幕五十中出| 秋霞伦理黄片| 97在线视频观看| 成人一区二区视频在线观看| av一本久久久久| 久久久欧美国产精品| 男女边吃奶边做爰视频| 日韩成人伦理影院| 一夜夜www| 色综合色国产| av国产久精品久网站免费入址| av福利片在线观看| 国产在视频线精品| 三级国产精品欧美在线观看| 熟女人妻精品中文字幕| 三级国产精品欧美在线观看| 在线免费观看不下载黄p国产| 日产精品乱码卡一卡2卡三| 韩国高清视频一区二区三区| 亚洲精品,欧美精品| 亚洲一区高清亚洲精品| 又大又黄又爽视频免费| 国产乱人偷精品视频| 99热网站在线观看| 联通29元200g的流量卡| 国产黄a三级三级三级人| 赤兔流量卡办理| 成人漫画全彩无遮挡| 亚洲欧美成人精品一区二区| 国产视频首页在线观看| 久久久久国产网址| 久久午夜福利片| 插逼视频在线观看| 久99久视频精品免费| 日日啪夜夜撸| 嘟嘟电影网在线观看| 日韩中字成人| 女的被弄到高潮叫床怎么办| 久久久久久久久大av| 亚洲天堂国产精品一区在线| 97超视频在线观看视频| 黄色欧美视频在线观看| 国产亚洲91精品色在线| 欧美日韩一区二区视频在线观看视频在线 | 激情五月婷婷亚洲| 国产探花极品一区二区| 欧美成人一区二区免费高清观看| 国产一级毛片七仙女欲春2| 国产黄色视频一区二区在线观看| 日本与韩国留学比较| 亚洲国产成人一精品久久久| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 午夜免费男女啪啪视频观看| 午夜亚洲福利在线播放| 欧美日韩综合久久久久久| 亚洲精品日本国产第一区| 午夜日本视频在线| 亚洲av电影不卡..在线观看| 久久久久久久久久黄片| 久久久精品免费免费高清| 青青草视频在线视频观看| 亚洲色图av天堂| 免费观看的影片在线观看| 22中文网久久字幕| 亚洲精品456在线播放app| 草草在线视频免费看| 国产一区有黄有色的免费视频 | 国产高清三级在线| 国产精品三级大全| 国产伦一二天堂av在线观看| av国产久精品久网站免费入址| 国内精品美女久久久久久| 亚洲国产色片| 成人毛片60女人毛片免费| 18禁裸乳无遮挡免费网站照片| 亚洲人成网站高清观看| 久久久久久久久久人人人人人人| 日本爱情动作片www.在线观看| 亚洲无线观看免费| 亚洲最大成人av| a级一级毛片免费在线观看| 国产亚洲91精品色在线| videos熟女内射| 免费观看a级毛片全部| 婷婷色av中文字幕| 26uuu在线亚洲综合色| 欧美高清性xxxxhd video| 国产伦精品一区二区三区视频9| 久久久久久久大尺度免费视频| 国产精品福利在线免费观看| 男人狂女人下面高潮的视频| 街头女战士在线观看网站| 婷婷色av中文字幕| 最新中文字幕久久久久| 亚洲av不卡在线观看| 看非洲黑人一级黄片| 久久久久久久国产电影| 最新中文字幕久久久久| 国产在视频线在精品| 婷婷六月久久综合丁香| 老师上课跳d突然被开到最大视频| 久久99热这里只有精品18| 如何舔出高潮| 91午夜精品亚洲一区二区三区| 久久久久性生活片| 日韩欧美 国产精品| 97精品久久久久久久久久精品| 神马国产精品三级电影在线观看| 免费黄色在线免费观看| 国产精品国产三级专区第一集| 最近的中文字幕免费完整| 男的添女的下面高潮视频| 人妻少妇偷人精品九色| 日韩人妻高清精品专区| 国产精品美女特级片免费视频播放器| 国产免费一级a男人的天堂| 一本一本综合久久| 国产女主播在线喷水免费视频网站 | 狠狠精品人妻久久久久久综合| 亚洲怡红院男人天堂| 最近最新中文字幕大全电影3| 国产亚洲91精品色在线| a级一级毛片免费在线观看| 国国产精品蜜臀av免费| 欧美高清成人免费视频www| 亚洲av电影在线观看一区二区三区 | videos熟女内射| 99热网站在线观看| 成人美女网站在线观看视频| 国产成人精品婷婷| 午夜免费观看性视频| 淫秽高清视频在线观看| 少妇的逼水好多| 欧美性感艳星| 日日摸夜夜添夜夜添av毛片| 99九九线精品视频在线观看视频| 尾随美女入室| 少妇裸体淫交视频免费看高清| 日本熟妇午夜| av卡一久久| 插逼视频在线观看| 亚洲av免费高清在线观看| 免费观看在线日韩| 禁无遮挡网站| 身体一侧抽搐| 欧美xxxx性猛交bbbb| 亚洲av国产av综合av卡| 日本黄色片子视频| 2021天堂中文幕一二区在线观| 国产视频内射| 黄片wwwwww| 九九爱精品视频在线观看| 久久久久精品久久久久真实原创| 色尼玛亚洲综合影院| 国产一区亚洲一区在线观看| 啦啦啦韩国在线观看视频| 国产精品日韩av在线免费观看| 国产精品不卡视频一区二区| 免费观看无遮挡的男女| 久久精品国产亚洲av涩爱| 国产精品精品国产色婷婷| 亚洲国产日韩欧美精品在线观看| 两个人视频免费观看高清| 国产精品.久久久| 成人午夜高清在线视频| 秋霞伦理黄片| 男女国产视频网站| 欧美3d第一页| 久久精品国产自在天天线| 99久久精品国产国产毛片| 亚洲人成网站在线观看播放| 日日撸夜夜添| 久久久a久久爽久久v久久| 亚洲18禁久久av| kizo精华| 一夜夜www| 色网站视频免费| 免费观看无遮挡的男女| 熟女电影av网| 国产淫片久久久久久久久| 在线a可以看的网站| 高清欧美精品videossex| 欧美精品一区二区大全| 美女高潮的动态| 美女主播在线视频| 三级毛片av免费| 神马国产精品三级电影在线观看| 一级av片app| 亚洲真实伦在线观看| 天堂俺去俺来也www色官网 | 一个人看的www免费观看视频| 大片免费播放器 马上看| 免费观看av网站的网址| 亚洲欧美日韩卡通动漫| 老司机影院毛片| 亚洲最大成人手机在线| 黄色日韩在线| 18禁裸乳无遮挡免费网站照片| 亚洲欧美一区二区三区黑人 | 国产69精品久久久久777片| av免费在线看不卡| 国产一区二区三区综合在线观看 | 五月伊人婷婷丁香| 美女被艹到高潮喷水动态| 成人无遮挡网站| 日韩欧美精品v在线| 美女被艹到高潮喷水动态| 成人无遮挡网站| 一级毛片黄色毛片免费观看视频| 欧美 日韩 精品 国产| 丰满乱子伦码专区| 最近中文字幕2019免费版| 蜜桃亚洲精品一区二区三区| 日韩av免费高清视频| 少妇的逼水好多| 精品久久久久久久末码| 黄片无遮挡物在线观看| 亚洲丝袜综合中文字幕| 一级毛片我不卡| 欧美日韩精品成人综合77777| 日韩欧美一区视频在线观看 | av专区在线播放| 国产成人a∨麻豆精品| 2021天堂中文幕一二区在线观| 久久草成人影院| a级毛片免费高清观看在线播放|